Piershale Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Piershale Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-202	Closed	-$9K	–	124
2016 Q3	$9K	Hold	202	–	–	0.01%	96
2016 Q2	$10K	Hold	202	–	–	0.01%	91
2016 Q1	$11K	Hold	202	–	–	0.01%	81
2015 Q4	$13K	Hold	202	–	–	0.01%	101
2015 Q3	$11K	Buy	+202	New	+$13.1K	0.01%	77
2015 Q2	–	Sell	-202	Closed	-$13K	–	145
2015 Q1	$13K	Hold	202	–	–	0.01%	73
2014 Q4	$12K	Hold	202	–	–	0.01%	95
2014 Q3	$11K	Hold	202	–	–	0.01%	84
2014 Q2	$11K	Hold	202	–	–	0.01%	97
2014 Q1	$11K	Hold	202	–	–	0.01%	81
2013 Q4	$8K	Hold	202	–	–	0.01%	74
2013 Q3	$8K	Hold	202	–	–	0.01%	78
2013 Q2	$8K	Buy	+202	New	+$7.87K	0.02%	64

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Piershale Financial Group's TEVA Position: Q4 2016 in Review

Piershale Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 202 shares — an estimated $9K sold.

Piershale Financial Group first reported a position in TEVA in Q2 2013 and held it in 13 quarters. The position peaked at $13K in Q4 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Piershale Financial Group reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Piershale Financial Group sold 202 Teva Pharmaceuticals shares in Q4 2016, an estimated $9K.
Piershale Financial Group first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 13 quarters.
Piershale Financial Group's Teva Pharmaceuticals position peaked at $13K in Q4 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Piershale Financial Group's 13F filing for Q4 2016, filed 18 Jan 2017.